• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Comparison of immune responses in patients infected with Vibrio cholerae O139 and O1.感染霍乱弧菌O139和O1患者的免疫反应比较。
Infect Immun. 1997 Sep;65(9):3571-6. doi: 10.1128/iai.65.9.3571-3576.1997.
2
Lipopolysaccharide- and cholera toxin-specific subclass distribution of B-cell responses in cholera.霍乱中B细胞反应的脂多糖和霍乱毒素特异性亚类分布
Clin Diagn Lab Immunol. 1999 Nov;6(6):812-8. doi: 10.1128/CDLI.6.6.812-818.1999.
3
Comparison of the vibriocidal antibody response in cholera due to Vibrio cholerae O139 Bengal with the response in cholera due to Vibrio cholerae O1.比较由霍乱弧菌O139孟加拉型引起的霍乱与由霍乱弧菌O1引起的霍乱中杀弧菌抗体反应。
Clin Diagn Lab Immunol. 1995 Nov;2(6):685-8. doi: 10.1128/cdli.2.6.685-688.1995.
4
Comparison of O-specific polysaccharide responses in patients following infection with O139 versus vaccination with a bivalent (O1/O139) oral killed cholera vaccine in Bangladesh.孟加拉国感染 O139 血清型与接种二价(O1/O139)口服霍乱死疫苗后患者 O 特异性多糖反应的比较。
mSphere. 2023 Oct 24;8(5):e0025523. doi: 10.1128/msphere.00255-23. Epub 2023 Aug 30.
5
Defining Polysaccharide-Specific Antibody Targets against Vibrio cholerae O139 in Humans following O139 Cholera and following Vaccination with a Commercial Bivalent Oral Cholera Vaccine, and Evaluation of Conjugate Vaccines Targeting O139.在感染 O139 霍乱弧菌和接种商业双价口服霍乱疫苗后,针对人类 O139 霍乱弧菌的多糖特异性抗体靶点的定义,以及针对 O139 的结合疫苗的评估。
mSphere. 2021 Aug 25;6(4):e0011421. doi: 10.1128/mSphere.00114-21. Epub 2021 Jul 7.
6
Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses.在孟加拉国受试者口服灭活二价霍乱弧菌O1/O139全细胞霍乱疫苗免疫后,在其黏膜表面检测到强大的肠道相关疫苗特异性抗体分泌细胞反应:与其他黏膜和全身反应的比较。
Vaccine. 2009 Feb 25;27(9):1386-92. doi: 10.1016/j.vaccine.2008.12.041. Epub 2009 Jan 13.
7
Immune response to the mannose-sensitive hemagglutinin in patients with cholera due to Vibrio cholerae O1 and O0139.O1群和O139群霍乱弧菌所致霍乱患者对甘露糖敏感血凝素的免疫反应
Clin Diagn Lab Immunol. 1997 Jul;4(4):429-34. doi: 10.1128/cdli.4.4.429-434.1997.
8
Plasma and memory B cell responses targeting O-specific polysaccharide (OSP) are associated with protection against Vibrio cholerae O1 infection among household contacts of cholera patients in Bangladesh.针对 O 特异性多糖(OSP)的血浆和记忆 B 细胞反应与孟加拉国霍乱患者家庭接触者对霍乱弧菌 O1 感染的保护有关。
PLoS Negl Trop Dis. 2018 Apr 23;12(4):e0006399. doi: 10.1371/journal.pntd.0006399. eCollection 2018 Apr.
9
Comparison of immune responses to the O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 in Bangladeshi adult patients with cholera.孟加拉国成年霍乱患者对霍乱弧菌O1型特异性多糖和脂多糖免疫反应的比较。
Clin Vaccine Immunol. 2012 Nov;19(11):1712-21. doi: 10.1128/CVI.00321-12. Epub 2012 Sep 19.
10
Secondary Vibrio cholerae-specific cellular antibody responses following wild-type homologous challenge in people vaccinated with CVD 103-HgR live oral cholera vaccine: changes with time and lack of correlation with protection.接种CVD 103-HgR口服霍乱活疫苗的人群在接受野生型同源菌株攻击后的霍乱弧菌特异性细胞抗体反应:随时间的变化及与保护作用的无关性
Infect Immun. 1993 Feb;61(2):729-33. doi: 10.1128/iai.61.2.729-733.1993.

引用本文的文献

1
Prevalent chromosome fusion in Vibrio cholerae O1.霍乱弧菌O1中普遍存在的染色体融合
Nat Commun. 2025 Jul 1;16(1):5830. doi: 10.1038/s41467-025-60699-0.
2
Diagnostic accuracy of saliva-based testing as a Vibrio cholerae surveillance tool among naturally infected patients.基于唾液检测作为霍乱弧菌自然感染患者监测工具的诊断准确性。
Clin Exp Immunol. 2025 Jan 21;219(1). doi: 10.1093/cei/uxae092.
3
Cholera toxin and O-specific polysaccharide immune responses after oral cholera vaccination with Dukoral in different age groups of Bangladeshi participants.口服 Dukoral 霍乱疫苗后不同年龄组孟加拉参与者的霍乱毒素和 O 特异性多糖免疫应答。
mSphere. 2024 Mar 26;9(3):e0056523. doi: 10.1128/msphere.00565-23. Epub 2024 Feb 23.
4
Vaccination of Rabbits with a Cholera Conjugate Vaccine Comprising O-Specific Polysaccharide and a Recombinant Fragment of Tetanus Toxin Heavy Chain Induces Protective Immune Responses against Vibrio cholerae O1.用包含 O 特异性多糖和破伤风毒素重链重组片段的霍乱结合疫苗给兔子接种可诱导针对霍乱弧菌 O1 的保护性免疫应答。
Am J Trop Med Hyg. 2023 Oct 2;109(5):1122-1128. doi: 10.4269/ajtmh.23-0259. Print 2023 Nov 1.
5
Comparison of O-specific polysaccharide responses in patients following infection with O139 versus vaccination with a bivalent (O1/O139) oral killed cholera vaccine in Bangladesh.孟加拉国感染 O139 血清型与接种二价(O1/O139)口服霍乱死疫苗后患者 O 特异性多糖反应的比较。
mSphere. 2023 Oct 24;8(5):e0025523. doi: 10.1128/msphere.00255-23. Epub 2023 Aug 30.
6
Long-term sialidase-specific immune responses after natural infection with cholera: Findings from a longitudinal cohort study in Bangladesh.自然感染霍乱后唾液酸酶的长期特异性免疫反应:来自孟加拉国纵向队列研究的结果。
Front Immunol. 2022 Dec 22;13:1067737. doi: 10.3389/fimmu.2022.1067737. eCollection 2022.
7
A polyvalent multiepitope protein cross-protects against infection in rabbit colonization and passive protection models.一种多价多表位蛋白在兔定植和被动保护模型中交叉保护免受感染。
Proc Natl Acad Sci U S A. 2022 Dec 13;119(50):e2202938119. doi: 10.1073/pnas.2202938119. Epub 2022 Dec 5.
8
Co-administration of Oral Cholera Vaccine With Oral Polio Vaccine Among Bangladeshi Young Children: A Randomized Controlled Open Label Trial to Assess Interference.口服霍乱疫苗与口服脊髓灰质炎疫苗联合接种在孟加拉国幼儿中的应用:一项评估干扰的随机对照开放性标签试验。
Clin Infect Dis. 2023 Jan 13;76(2):263-270. doi: 10.1093/cid/ciac782.
9
Systemic, Mucosal, and Memory Immune Responses following Cholera.霍乱后的全身、黏膜和记忆免疫反应
Trop Med Infect Dis. 2021 Oct 27;6(4):192. doi: 10.3390/tropicalmed6040192.
10
Scalable production and immunogenicity of a cholera conjugate vaccine.可扩展生产和霍乱结合疫苗的免疫原性。
Vaccine. 2021 Nov 16;39(47):6936-6946. doi: 10.1016/j.vaccine.2021.10.005. Epub 2021 Oct 27.

本文引用的文献

1
A highly selective gelatin-taurocholate-tellurite medium for the isolation of Vibrio cholerae.一种用于分离霍乱弧菌的高选择性明胶-牛磺胆酸盐-亚碲酸盐培养基。
Trans R Soc Trop Med Hyg. 1961 Sep;55:440-2. doi: 10.1016/0035-9203(61)90090-6.
2
RAPID IDENTIFICATION OF VIBRIO CHOLERAE BY DARKFIELD MICROSCOPY.通过暗视野显微镜快速鉴定霍乱弧菌
Bull World Health Organ. 1964;30(6):827-31.
3
Immune response to the mannose-sensitive hemagglutinin in patients with cholera due to Vibrio cholerae O1 and O0139.O1群和O139群霍乱弧菌所致霍乱患者对甘露糖敏感血凝素的免疫反应
Clin Diagn Lab Immunol. 1997 Jul;4(4):429-34. doi: 10.1128/cdli.4.4.429-434.1997.
4
Intestinal and systemic immune responses in humans after oral immunization with a bivalent B subunit-O1/O139 whole cell cholera vaccine.用二价B亚单位-O1/O139全细胞霍乱疫苗口服免疫后人体的肠道和全身免疫反应
Vaccine. 1996 Oct;14(15):1459-65. doi: 10.1016/s0264-410x(96)00071-0.
5
Structural analysis of the O-antigen-core region of the lipopolysaccharide from Vibrio cholerae O139.
Carbohydr Res. 1996 Aug 26;290(1):59-65. doi: 10.1016/0008-6215(96)00131-0.
6
Epidemiology & molecular biology of Vibrio cholerae O139 Bengal.霍乱弧菌O139孟加拉型的流行病学与分子生物学
Indian J Med Res. 1996 Jul;104:14-27.
7
Immune mechanisms and protective antigens of Vibrio cholerae serogroup O139 as a basis for vaccine development.霍乱弧菌O139血清群的免疫机制及保护性抗原作为疫苗研发的基础
Infect Immun. 1996 Sep;64(9):3778-85. doi: 10.1128/iai.64.9.3778-3785.1996.
8
Construction and characterization of a potential live oral carrier-based vaccine against Vibrio cholerae O139.一种潜在的基于活口服载体的霍乱弧菌O139疫苗的构建与特性分析
Infect Immun. 1996 Sep;64(9):3565-70. doi: 10.1128/iai.64.9.3565-3570.1996.
9
Comparison of the vibriocidal antibody response in cholera due to Vibrio cholerae O139 Bengal with the response in cholera due to Vibrio cholerae O1.比较由霍乱弧菌O139孟加拉型引起的霍乱与由霍乱弧菌O1引起的霍乱中杀弧菌抗体反应。
Clin Diagn Lab Immunol. 1995 Nov;2(6):685-8. doi: 10.1128/cdli.2.6.685-688.1995.
10
Induction and assessment of immunity at enteromucosal surfaces in humans: implications for vaccine development.人体肠黏膜表面免疫的诱导与评估:对疫苗研发的启示
Clin Infect Dis. 1993 Mar;16 Suppl 2:S106-16. doi: 10.1093/clinids/16.supplement_2.s106.

感染霍乱弧菌O139和O1患者的免疫反应比较。

Comparison of immune responses in patients infected with Vibrio cholerae O139 and O1.

作者信息

Qadri F, Wennerås C, Albert M J, Hossain J, Mannoor K, Begum Y A, Mohi G, Salam M A, Sack R B, Svennerholm A M

机构信息

International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka.

出版信息

Infect Immun. 1997 Sep;65(9):3571-6. doi: 10.1128/iai.65.9.3571-3576.1997.

DOI:10.1128/iai.65.9.3571-3576.1997
PMID:9284121
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC175508/
Abstract

Vibrio cholerae O139 has recently emerged as the second etiologic agent of cholera in Asia. A study was carried out to evaluate the induction of specific immune responses to the organism in V. cholerae O139-infected patients. The immune responses to V. cholerae O139 Bengal were studied in patients by measuring antibody-secreting cells (ASC), as well as vibriocidal and antitoxic antibodies in the circulation. These responses were compared with those in patients with V. cholerae O1 disease. Strong immunoglobulin A (IgA) and IgM ASC responses were seen against the homologous lipopolysaccharide or serogroup of V. cholerae. The magnitude and isotype of the responses were similar in O139- and O1-infected patients. Vibriocidal antibody responses were seen against bacteria of the homologous but not heterologous serogroup, and these responses reflect the lack of cross-protection between the infections caused by the two serogroups. The two groups of patients showed comparable cholera toxin-specific ASC responses, with the IgG isotype dominating over the IgA isotype, as well as comparable antitoxic immune responses in plasma. These results suggest that despite having a polysaccharide capsule, V. cholerae O139 induces systemic and intestine-derived ASC responses in peripheral blood comparable to those seen in patients with V. cholerae O1 disease.

摘要

霍乱弧菌O139最近已成为亚洲霍乱的第二种病原体。开展了一项研究,以评估霍乱弧菌O139感染患者对该病原体特异性免疫反应的诱导情况。通过测量抗体分泌细胞(ASC)以及循环中的杀弧菌抗体和抗毒素抗体,研究了患者对霍乱弧菌O139孟加拉型的免疫反应。并将这些反应与霍乱弧菌O1疾病患者的反应进行了比较。观察到针对霍乱弧菌同源脂多糖或血清群的强烈免疫球蛋白A(IgA)和IgM ASC反应。O139感染患者和O1感染患者的反应强度和亚型相似。观察到针对同源血清群细菌的杀弧菌抗体反应,但未观察到针对异源血清群细菌的反应,这些反应反映了这两个血清群引起的感染之间缺乏交叉保护。两组患者的霍乱毒素特异性ASC反应相当,IgG亚型占主导地位,高于IgA亚型,血浆中的抗毒素免疫反应也相当。这些结果表明,尽管霍乱弧菌O139有多糖荚膜,但它在外周血中诱导的全身和肠道来源的ASC反应与霍乱弧菌O1疾病患者的反应相当。